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Background: Stigmatization among healthcare providers towards mental illnesses can present obstacles to
effective caregiving. This may be especially the case for borderline personality disorder (BPD). Our study measured
the impact of a three hour workshop on BPD and dialectical behavior therapy (DBT) on attitudes and behavioral
intentions of healthcare providers towards persons with BPD as well as mental illness more generally. The
intervention involved educational and social contact elements, all focused on BPD.
Methods: The study employed a pre-post design. We adopted the approach of measuring stigmatization towards
persons with BPD in one half of the attendees and stigmatization towards persons with a mental illness in the other
half. The stigma-assessment tool was the Opening Minds Scale for Healthcare Providers (OMS-HC). Two versions of
the scale were employed – the original version and a ‘BPD-specific’ version. A 2x2 mixed model factorial analysis of
variance (ANOVA) was conducted on the dependent variable, stigma score. The between-subject factor was survey
type. The within-subject factor was time.
Results: The mixed-model ANOVA produced a significant between-subject main effect for survey type, with stigma
towards persons with BPD being greater than that towards persons with a mental illness more generally. A significant
within-subject main effect for time was also observed, with participants showing significant improvement in stigma
scores at Time 2. The main effects were subsumed by a significant interaction between time and survey type.
Bonferroni post hoc tests indicated significant improvement in attitudes towards BPD and mental illness more
generally, although there was a greater improvement in attitudes towards BPD.
Conclusions: Although effectiveness cannot be conclusively demonstrated with the current research design,
results are encouraging that the intervention was successful at improving healthcare provider attitudes and
behavioral intentions towards persons with BPD. The results further suggest that anti stigma interventions
effective at combating stigma against a specific disorder may also have positive generalizable effects towards a
broader set of mental illnesses, albeit to a lessened degree.
Keywords: Stigma, Borderline personality disorder, Healthcare providers, Anti-stigma program, Psycho-education
intervention, Dialectical behavior therapy, Social contact* Correspondence: sknaak@mentalhealthcommission.ca
1Opening Minds Anti-Stigma Initiative, Mental Health Commission of Canada,
110 Quarry Park Blvd, Suite 320, T2C 3G3 Calgary, AB, Canada
Full list of author information is available at the end of the article
© 2015 Knaak et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Knaak et al. Borderline Personality Disorder and Emotion Dysregulation  (2015) 2:9 Page 2 of 8Background
Stigmatization among healthcare providers towards per-
sons with a mental illness is believed to present obstacles
to effective caregiving [1-4]. This may be especially the
case for persons with borderline personality disorder
(BPD), where it has been suggested that negative reactions
can lead to counter-therapeutic conditions including pre-
mature termination of treatment, rationalization of treat-
ment failures, a lower likelihood of forming an effective
treatment alliance with patients, emotional and social dis-
tancing, difficulty empathizing, a lack of belief in recovery,
and perceptions of patients as powerful, unrelenting,
dangerous, manipulative and more in control of their be-
haviors than other patients [1,5-9].
Research has found that clinicians commonly report
experiencing anger, frustration, inadequacy, and feelings
of being challenged in response to patients with BPD
[10,11]. Also, when comparing BPD to other highly stig-
matized disorders such as schizophrenia and affective
disorder for example, attitudes and behaviors towards
BPD have tended to be more negative [5,6,8]. It has thus
been argued that there is considerable need for educa-
tion and training aimed at improving healthcare pro-
viders’ attitudes, as well as their ability to interact
effectively with patients with BPD [12-14].
There is some research on psycho-education as an ef-
fective intervention for BPD with patients and family
members [15-19]. There is also some research suggesting
psycho-education can improve clinician attitudes [12-14].
Our study sought to contribute to this literature by exam-
ining the extent to which a three hour workshop on BPD
and dialectical behavior therapy (DBT) was effective at im-
proving attitudes and behavioral intentions of healthcare
providers towards patients with BPD. Our study design
also offered the opportunity to examine spillover effects of
the intervention; namely, the impact of this disorder-
specific intervention on attitudes towards persons with a
mental illness more generally.
The program was developed by Dr. Kathy Fitch, MD,
FRCPC, a specialist in DBT and a general adult inpatient
psychiatrist in Calgary, Canada. The program was de-
livered at a Calgary hospital on November 21, 2012 by
Dr. Fitch and three co-presenters to a group of 230
healthcare providers, as part of an education series tar-
geting front-line community and outreach service pro-
viders as well as hospital-based providers. Workshop
attendees were eligible to receive continuing medical
education credits for their participation. Participants
registered for the workshop ahead of time. Table 1 pro-
vides demographic information about program attendees.
The program’s objective was to improve healthcare pro-
viders’ attitudes and behavioral intentions towards persons
with BPD through a combination of education and skills
training, as well as social contact. The workshop containeda number of ingredients shown to be effective for improv-
ing attitudes among healthcare providers towards persons
with mental illnesses [20], including an educational/skills
training component designed to improve healthcare pro-
viders’ abilities to effectively interact with and help pa-
tients, education to correct common misperceptions,
social contact in the form of a live personal testimony
from a person with lived experience of BPD, an emphasis
on and demonstration of recovery (including a case study
which exemplified recovery and achievement), and an en-
thusiastic facilitator who set the tone and modeled
person-first (as opposed to disorder-first) language and
behavior.
Our interest in understanding the impact of this inter-
vention on attitudes and behavioral intentions towards
both persons with BPD and persons with a mental illness
arose from larger questions about the possible
generalizability [21,22] or ‘spillover effects’ of disorder-
specific interventions. We were interested in informing the
question about whether a generalist or specialist approach
is the better strategy for anti-stigma programming [23,24],
especially for disorders characterized by high levels of
stigmatization. For example, if a targeted (i.e., diagnosis-
specific) intervention is effective at reducing stigma to-
wards the specific disorder and its generalizability to other
disorders and/or to mental illness more generally is neutral
or positive, the relevance and value of developing and de-
livering such programming may be increased. However, if
spillover effects are negative, a determination of program
success becomes decidedly more complex.
Methods
Our interest was to examine the extent to which the
intervention led to a change in perceptions towards persons
with BPD, as well as towards persons with a mental illness
more generally. The study employed a pre-post design. We
adopted the approach of measuring stigmatization towards
persons with BPD in one half of the attendees and
stigmatization towards persons with a mental illness in
general in the other half. The stigma-assessment tool used
was the Opening Minds Scale for Healthcare Providers
(OMS-HC) [25,26], a validated scale that measures health
care providers’ attitudes and behavioral intentions towards
mental illness and persons with a mental illness. To
complete the scale, respondents are asked the extent to
which they agree or disagree with a series of items on a
5-point scale: strongly agree (1), agree (2), neither agree
nor disagree (3), disagree (4), or strongly disagree (5). To
create a total scale score for the OMS-HC, all 15 items
are summed for each participant with appropriate items
reverse scored. Total scores can range from 15 to 75,
with lower scores indicating less stigma.
The scale also captures three main dimensions of
stigma: negative attitudes, willingness to disclose/seek
Table 1 Participant demographic information: all participants and by scale type
Original OMS-HC BPD-specific OMS-HC All participants
(n = 94) (n = 93) (n = 187)
Gender
Male 15 (16.0%) 13 (14.0%) 28 (15.0%)
Female 79 (84.0%) 80 (86.0%) 159 (85.0%)
Age (mean) 39.0 yrs 39.2 yrs 39.1 yrs
Occupation
Social worker 33 (35.1%) 40 (43.0%) 73 (39.0%)
Nurse 13 (13.8%) 14 (15.1%) 27 (14.4%)
Counselor 14 (14.9%) 8 (8.6%) 22 (11.8%)
Occupational therapist 8 (8.5%) 11 (11.8%) 19 (10.2%)
Psychologist/psychiatrist 11 (11.7%) 4 (4.4%) 15 (8.0%)
Student 6 (6.4%) 3 (3.2%) 9 (4.8%)
Director/manager 5 (5.3%) 3 (3.3%) 8 (4.2%)
Other 3 (3.2%) 8 (8.6%) 11 (5.9%)
Years in practice (mean) 12.7 yrs 11.7 yrs 12.2 yrs
Ever been treated for a mental illness?
No 64 (68.1%) 67 (72.0%) 131 (70.1%)
Yes 30 (31.9%) 26 (28.0%) 56 (29.9%)
Ever been treated for BPD?
No 90 (95.7%) 92 (98.9%) 182 (97.3)%
Yes 4 (4.3%) 1 (1.1%) 5 (2.7%)
Ever treated a person with a mental illness?
No 13 (14.0%) 20 (21.5%) 33 (17.7%)
Yes 80 (86.0%) 73 (78.5%) 153 (82.3%)
Specialize in working with patients with BPD?
No 80 (85.1%) 79 (85.9%) 159 (85.5%)
Yes 14 (14.9%) 13 (14.1%) 27 (14.5%)
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ample of an item from the ‘negative attitudes’ subscale is
the statement, “I am more comfortable helping a person
with has a physical illness than I am helping a person
who has a mental illness.” An example of an item from
the ‘willingness to disclose’ subscale is the statement, “If
I had a mental illness, I would tell my friends.” An ex-
ample from the ‘preference for social distance subscale’
is the statement, “If a colleague with whom I worked
told me they had a managed mental illness, I would be
just as willing to work with him/her.”
Because the intention was to measure the program’s
impact on stigmatizing attitudes against persons with a
mental illness as well as BPD, two versions of the scale
were employed and randomly given to participants – the
original version and a ‘BPD-specific’ version. The ‘BPD-
specific’ version replaced each instance of the phrase
‘mental illness’ (which occurs in each item on the scale)
with the term ‘borderline personality disorder’. Forexample, the statement, ‘If a colleague with whom I work
told me they had a mental illness, I would be just as will-
ing to work with him/her’ was changed to, ‘If a colleague
with whom I work told me they had borderline person-
ality disorder, I would be just as willing to work with
him/her.’ Demographic information, including gender,
age, occupation, average years in practice, and previous
experience with mental illness and BPD was also collected.
Ethics approval was granted by the Conjoint Health
Research Ethics Board at the University of Calgary.
An assumption invoked with the study design is that the
modified scale measured stigma against BPD whereas the
original version of the scale measured mental illness in
general. Cronbach’s alphas for both versions of the scale
were calculated. Alphas for the original OMS-HC scale
were .73 at pre-test and .81 at post-test. For the BPD-
specific version alphas were .79 at pre-test and .80 at post-
test, indicating an acceptable level of internal consistency
for both versions of the scale at both time points.
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subscale OMS-HC scores at pre and post time points. Re-
spondents with more than three missing items were
dropped from the analysis. Missing items were filled with
each respondent’s mean item value. Examination of a
histogram and QQ plot confirmed that scores were dis-
tributed normally. To assess the overall effectiveness of
the presentation on stigma towards persons with a mental
illness and towards persons with BPD, a 2×2 mixed model
factorial analysis of variance (ANOVA) was conducted on
the dependent variable, stigma score. The between-subject
factor was survey type (OMS-HC versus ‘BPD-specific’
OMS-HC) and the within-subject factor was time (pre
intervention versus post intervention). Data were analyzed
using PASW 18 [27].
Results
Of the 230 participants registered for the session, 191
pre and post surveys were completed (94 paired OMS-HC
surveys; 97 paired ‘BPD-specific’ surveys), representing a
response rate of 83%. Participant demographics by survey
type showed a high degree of similarity between the
two sub-samples, suggesting the randomization process
worked as designed (Table 1).
The mixed-model ANOVA produced a significant
between-subject main effect for survey type (comparing
stigma scores for persons with borderline personalityFigure 1 Pre-post OMS-HC score: original scale and BPD version.disorder against stigma scores towards persons with a
mental illness), F (1,189) = 39.63, p < .001, ƞ2partial = .173,
with stigma towards persons with borderline personality
disorder (M = 35.20, SE = .61) being greater than
that towards persons with a mental illness (M = 29.81,
SE = .60). The ANOVA also produced a significant
within-subject main effect for time, F (1,189) = 72.46,
p < .001, ƞ2partial = .277, with participants showing sig-
nificant improvement in stigma scores at Time 2 (post
intervention M = 31.05, SE = .46; pre intervention M =
33.96, SE = .47). The main effects were, however, sub-
sumed by a significant interaction between time and
survey type, F (1,189) = 28.71, p < .001 ƞ2partial = .132.
Bonferroni post hoc tests indicated participants had
greater reduction in stigmatizing attitudes towards per-
sons with borderline personality disorder than they did
towards persons with a mental illness more generally,
although stigma towards both mental illness and BPD
were significantly reduced (pre intervention BPD score,
M = 37.56, SE = .66; post intervention BPD score, M =
32.83, SE = .65, p < .001; pre intervention mental ill-
ness score, M = 30.35, SE = .65; post intervention mental
illness score, M = 29.28, SE = .64, p = .026). These results
are illustrated in Figure 1.
Results for the three subscales replicated the results of
the full scale (Table 2). Similarly, post hoc tests showed
greater improvements towards persons with BPD than
Table 2 Mixed model ANOVA results for OMS-HC subscales: time and survey type
Time Survey type Time* survey interaction
Mean (SE) Assessment of
significance
Mean (SE) Assessment of
significance
Mean difference (SE) Assessment of
significance
Attitudes towards mental illness T1 = 10.53 (.20)
T2 = 9.51 (.19)
F (1,189) = 39.83
ƞ2partial = .174
p < .001
Original = 8.91 (.25)
BPD = 11.14 (.25)
F (1,189) = 40.32
ƞ2partial = .176
p < .001
T1 Orig. vs. BPD =2.98 (.40)
T2 Orig. vs. BPD =1.48 (.37)
F (1,189) = 21.96
ƞ2partial = .104
p < .001
Disclosure/help-seeking T1 = 10.84 (.19)
T2 = 10.15 (.19)
F (1,188) = 19.47
ƞ2partial = .094
p < .001
Original = 9.77 (.24)
BPD = 11.22 (.25)
F (1,189) = 17.84
ƞ2partial = .087
p < .001
T1 Orig. vs. BPD =1.94 (.38)
T2 Orig. vs. BPD =0.97 (.38)
F (1,188) = 9.83
ƞ2partial = .050
p = .002
Preference for social distance T1 = 11.26 (.17)
T2 = 10.38 (.15)
F (1,189) = 34.32
ƞ2partial = .154
p < .001
Original = 9.35 (.20)
BPD = 12.29 (.20)
F (1,189) = 112.53
ƞ2partial = .373
p < .001
T1 Orig. vs. BPD =3.26 (.33)
T2 Orig. vs. BPD =2.63 (.30)
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all three subscales (Table 3). While significant improve-
ments were observed on all three factors for the BPD-
version of the scale, only preference for social distance
showed a significant improvement from pre to post
workshop on the original scale (Table 3).
In an exploratory analysis we examined gender, previ-
ous experience with a mental illness, and specialty in
treating patients with BPD as potential moderators of
the intervention’s effects. No significant interactions
were found, although lower baseline scores were observed
among women (both versions of the scale), healthcare
providers who had previously been diagnosed with a men-
tal illness (original OMS-HC only), and healthcare pro-
viders who specialized in treating patients with BPD (both
versions of the scale).
Discussion
Results showed stigma towards persons with BPD was
significantly higher than that against persons with a
mental illness more generally. Scores on the BPD-
specific scale remained high, higher even than the base-
line scores for mental illness more generally, even after
the intervention. This is consistent with previous re-
search on the stigma associated with persons with BPD.
Our results provide additional evidence that BPD is a
highly stigmatized disorder amongst healthcare pro-
viders, and lends support to the argument that there is
considerable need for anti-stigma programming target-
ing this disorder. These findings also add further support
to literature showing that stigma differs by diagnostic
group [28,29]. In keeping with this, it is worth noting
that the pre and post ratings seen with the modified
scale were higher than any ratings previously observed
in evaluations using the original form of the OMS-HC
scale, while the ratings observed in this study using the
original version of the scale were comparable to those
observed in other evaluations [30,31].
Results suggest that the targeted intervention was
successful at improving healthcare provider attitudes to-
wards persons with BPD and a mental illness more gen-
erally, although the improvement in attitudes towards
persons with a mental illness was considerably smaller
than that towards persons with BPD. There are two
likely reasons why the intervention proved to improve
attitudes towards BPD to a greater degree than towards
mental illness more generally. The first is that that theTable 3 Pre-post mean score change for OMS-HC subscales: b
Attitudes towards mental illness Original OMS-HC BPD OMS-HC
Disclosure/help-seeking Original OMS-HC BPD OMS-HC
Preference for social distance Original OMS-HC BPD OMS-HCintervention was specifically designed to address BPD.
Secondly, the higher stigma scores observed for BPD
may be said to indicate greater severity of stigma com-
pared to that of mental illness more generally. As such,
there was more room for participant’s scores to improve
after the intervention on the BPD measure.
Such results further suggest that attitudes towards a
highly stigmatized disorder like BPD can be improved
through relatively short interventions, if those interven-
tions are designed and delivered properly [20]. It is also
noteworthy that significant reductions in stigma were
achieved with only a three hour program, even when the
target audience was a group of practicing providers with
significant experience of mental illness outside of this
workshop. These findings are encouraging from the per-
spective of stigma reduction, as well as the value of
psycho-education more generally as an effective inter-
vention for BPD.
The results further suggest that anti stigma interven-
tions effective at combating stigma against a specific
disorder may also have positive generalizable effects to-
wards a broader set of mental illnesses, albeit to a less-
ened degree. However, it is possible that at least some of
the improvement in the group completing the standard
scale was due to non-specific effects that would have
occurred in the absence of an anti-stigma intervention.
A controlled study would be required to assess this pos-
sibility. Although more research is required, these are
encouraging findings for healthcare organizations look-
ing for ways to combat stigma in the most effective and
efficient manner possible.
These results as well as others [24,32] suggest that the
generalizability of anti-stigma interventions should be a
focus of future research. One may speculate, for ex-
ample, that contact-based interventions that include first
person narratives from people with several different dis-
orders may be more generalizable than those that focus
on just one. Also, these results raise the possibility that
the impact of contact-based education in a particular
setting may be greater if information and first-person
narratives included in the programs relate to the disor-
ders encountered most often in those settings. Existing
evidence suggests that different diagnostic labels are
likely to trigger specific sets of beliefs which, in turn can
produce distinct emotional and behavioral reactions to-
ward those being labeled [33,34]. These distinctions may
be particularly important for anti-stigma programs thaty survey type
T1 M (SE) T2 M (SE) p (Bonferroni)
9.04 (.28) 12.02 (.29) 8.78 (.26) 10.25 (.27) .248 < .001
9.87 (.27) 11.81 (.27) 9.67 (.27) 10.64 (.27) .365 < .001
9.63 (.23) 12.89 (.24) 9.07 (.21) 11.70 (.21) .008 < .001
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play a larger role in structuring the attitudes and behaviors
of health professionals than is the case among members of
the general population. Given this, disorder-specific anti-
stigma programs delivered to health care professionals
may be more effective at addressing these stigma than a
disorder-generic program.
There are limitations to this study. Our study did not
include a control group to measure for non-specific
effects on the scales. Our study’s objective was not so
much to determine if the intervention had greater effect-
iveness than non-specific effects, but more to determine
differences between two randomized sets of question-
naire responses measuring two different types of stigma.
While future research with a randomized control group
is important to determine more conclusively the effect-
iveness of the intervention, the randomization process
undertaken in the current study would have protected
against certain effects as social desirability bias. It should
also be noted that previous research on the OMS-HC
[25] did not find scores correlating strongly with social
desirability.
Secondly, although alpha scores for the modified scale
suggested an acceptable level of internal consistency and
were similar to those observed for the original scale, the
full psychometric performance of the modified scale
remains under-examined. The assumption that the modi-
fied scale measured BPD is supported by face validity only.
Further research on the adaptability of the OMS-HC to
measure stigma against persons with particular mental
disorders is a fruitful area for future research. Stigma is a
complex concept with multiple facets and existing at mul-
tiple levels, which cannot be fully captured in a single
measure [35,36]. Our study assessed healthcare providers’
attitudes and behavioral intentions towards persons with
BPD and a mental illness more generally. It is not known
how these findings translate into actual behaviors or spe-
cific interactions between healthcare providers and their
clients with BPD or other mental illnesses.Conclusion
Although effectiveness cannot be conclusively demon-
strated with the current research design, results are
encouraging that the intervention was successful at im-
proving healthcare provider attitudes and behavioral
intentions towards persons with BPD. The results fur-
ther suggest that anti stigma interventions effective at
combating stigma against a specific disorder may also
have positive generalizable effects towards a broader
set of mental illnesses, albeit to a lessened degree.
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